ATCC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ATCC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9303
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ATCC is a nonprofit bioresource center and research organization that provides biological products, technical services and educational programs. The organization acquires, preserves, develops, authenticates, produces, and distributes standard reference microorganisms, cell lines and other materials. Its products include nucleic acids, cells and microorganisms, testing and characterization, cells extracts, culture reagents, quality control strains, proteins and cell extracts. ATCC’s services include production and characterization, biorepository management, testing services, and deposit services. The organization offers custom testing services for mycoplasma detection and human cell line authentication. It serves research and life science industry. The organization also provides storage of biomaterials through its facility. ATCC is headquartered in Manassas, Virginia, the US.

ATCC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ATCC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ATCC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ATCC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ATCC, Medical Devices Deals, 2012 to YTD 2018 8
ATCC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
ATCC, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Horizon Discovery Enters Into Licensing Agreement With ATCC 10
ATCC Forms Joint Venture with ILSE 11
BioCision Enters Into Co-Development Agreement With ATCC 12
Licensing Agreements 13
Biomatrica Enters Into Licensing Agreement With ATCC For DNAstable And RNAstable Reagents 13
ATCC Enters into Licensing Agreement with Baylor College of Medicine 14
ATCC Enters Into Licensing Agreement With Life Technologies For GFP Technology 15
ATCC – Key Competitors 16
ATCC – Key Employees 17
ATCC – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Joint Venture 18
Recent Developments 19
Strategy And Business Planning 19
Apr 21, 2017: ATCC Opens Doors to New High-Tech Biorepository in Gaithersburg, MD 19
Product News 20
Nov 20, 2017: ATCC develops novel in vitro model to investigate drug candidates for cancer metastasis 20
Other Significant Developments 21
Jul 10, 2018: ATCC launches new PCR-based Mycoplasma Detection Service 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
ATCC, Pharmaceuticals & Healthcare, Key Facts 2
ATCC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
ATCC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ATCC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ATCC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ATCC, Medical Devices Deals, 2012 to YTD 2018 8
ATCC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Horizon Discovery Enters Into Licensing Agreement With ATCC 10
ATCC Forms Joint Venture with ILSE 11
BioCision Enters Into Co-Development Agreement With ATCC 12
Biomatrica Enters Into Licensing Agreement With ATCC For DNAstable And RNAstable Reagents 13
ATCC Enters into Licensing Agreement with Baylor College of Medicine 14
ATCC Enters Into Licensing Agreement With Life Technologies For GFP Technology 15
ATCC, Key Competitors 16
ATCC, Key Employees 17
ATCC, Joint Venture 18

List of Figures
ATCC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ATCC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ATCC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ATCC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ATCC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ATCC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ATCC, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[ATCC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Vivimed Labs Ltd (VIVIMEDLAB):企業の財務・戦略的SWOT分析
    Vivimed Labs Ltd (VIVIMEDLAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Johnson & Johnson:企業の戦略・SWOT・財務情報
    Johnson & Johnson - Strategy, SWOT and Corporate Finance Report Summary Johnson & Johnson - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Institute of Organic Chemistry and Biochemistry AS CR vvi:製薬・医療:M&Aディール及び事業提携情報
    Summary Institute of Organic Chemistry and Biochemistry AS CR vvi (IOCB) is a research institute that offers organic chemistry and biochemistry for medical and environmental applications. The institute’s scientific research includes the fields of physico-organic chemistry and biochemistry, molecular …
  • KDH Defense Systems, Inc.:企業の戦略・SWOT・財務情報
    KDH Defense Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary KDH Defense Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Wilbur-Ellis Company:企業の戦略・SWOT・財務情報
    Wilbur-Ellis Company - Strategy, SWOT and Corporate Finance Report Summary Wilbur-Ellis Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Edge Therapeutics Inc (EDGE):製薬・医療:M&Aディール及び事業提携情報
    Summary Edge Therapeutics Inc (Edge Therapeutics) is a clinical-stage biotechnology company that discovers, develops and commercializes hospital-based therapies. The company offers hospital based therapies capable of transforming treatment paradigms in the management of life-threatening, acute neuro …
  • Zara Investment (Holding) Co Ltd:企業の戦略・SWOT・財務情報
    Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Duke Energy Corp (DUK):企業の財務・戦略的SWOT分析
    Duke Energy Corp (DUK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Adler Solar Services GmbH:電力:M&Aディール及び事業提携情報
    Summary ADLER Solar Services GmbH (ADLER Solar), formerly ADLER Personal Services GmbH, is a renewable energy company which provides technical solutions and services for solar photovoltaic (PV) industry. The company's service offerings include engineering, procurement and construction management; in …
  • Celldex Therapeutics, Inc.:企業のM&A・事業提携・投資動向
    Celldex Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Celldex Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Atkore International Group Inc (ATKR):企業の財務・戦略的SWOT分析
    Atkore International Group Inc (ATKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Ames Construction Inc:企業の戦略的SWOT分析
    Ames Construction Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Lalique Group S.A:企業の戦略・SWOT・財務情報
    Lalique Group S.A - Strategy, SWOT and Corporate Finance Report Summary Lalique Group S.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Grifols SA (GRF):製薬・医療:M&Aディール及び事業提携情報
    Summary Grifols SA (Grifols) focuses at improving the health and well-being of people around the world. It carries out the research, development, manufacturing and marketing of plasma-derived therapies, hospital pharmacy products and diagnostic technology for clinical use. The company specializes in …
  • Encavis AG:企業のM&A・事業提携・投資動向
    Encavis AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Encavis AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Insulet Corp (PODD):医療機器:M&Aディール及び事業提携情報
    Summary Insulet Corp (Insulet) is a medical device company that develops, manufactures and distributes insulin management systems for diabetic patients. Its OmniPod insulin management system is a continuous insulin delivery system for insulin dependent diabetic s. Omnipod system consists of a dispos …
  • Southern Co (SO):企業の財務・戦略的SWOT分析
    Southern Co (SO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Hellenic Bank Public Company Ltd:企業の戦略・SWOT・財務情報
    Hellenic Bank Public Company Ltd - Strategy, SWOT and Corporate Finance Report Summary Hellenic Bank Public Company Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • General Electric Co (GE):石油・ガス:M&Aディール及び事業提携情報
    Summary General Electric Company (GE) is a digital industrial company. It offers a range of industrial, infrastructure and financial services globally. The company offers a range of products and services ranging from aircraft engines, power generation and oil and gas production equipment to medical …
  • AMP Solar Group Inc:電力:M&Aディール及び事業提携情報
    Summary AMP Solar Group Inc (AMP Solar Group) is an alternative energy company that offers solar and photovoltaic turnkey solutions. The company provides development of rooftop and ground based solar projects. It builds solar power projects in government and commercial sectors. AMP Solar Group opera …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆